Overview Diosmin as Adjuvant Therapy in Treatment of Non-bleeding Peptic Ulcer Status: Recruiting Trial end date: 2025-06-01 Target enrollment: Participant gender: Summary The aim of the study is to evaluate the safety and efficacy of diosmin as adjuvant therapy in treatment of non-bleeding peptic ulcer patients. Phase: Phase 3 Details Lead Sponsor: Tanta University